Two Sigma Advisers’s Elevance Health ELV Stock Holding History

Two Sigma Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-8,000	Closed	-$655K	–	2165
2013 Q2	$655K	Buy	+8,000	New	+$599K	0.01%	1144

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Two Sigma Advisers's ELV Position: Q3 2025 in Review

Two Sigma Advisers sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 2,100 shares — an estimated $817K sold.

Two Sigma Advisers first reported a position in ELV in Q4 2013 and held it in 41 quarters. The position peaked at $348M in Q3 2023. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Two Sigma Advisers reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Two Sigma Advisers sold 2,100 Elevance Health shares in Q3 2025, an estimated $817K.
Two Sigma Advisers first reported a position in Elevance Health in Q4 2013 and held it in 41 quarters.
Two Sigma Advisers's Elevance Health position peaked at $348M in Q3 2023.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.